Chandan Mehta
Overview
Explore the profile of Chandan Mehta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shah U, Desai M, Samant V, Mehta C
J Orthop Case Rep
. 2024 Dec;
14(12):185-191.
PMID: 39669062
Introduction: Dual mobility (DM) total hip replacement (THR) features an acetabular component with an unconstrained tripolar build which ensures a greater range of motion without provoking any dislocation.We report three...
2.
Varelas P, Kananeh M, Brady P, Holden D, Mehta C, Ata A, et al.
Crit Care Med
. 2023 Nov;
52(2):e58-e66.
PMID: 37966309
Objectives: Systematic reviews have revealed that up to 50% of patients with brain death have residual hypothalamic/pituitary activity based on the absence of central diabetes insipidus (DI). We hypothesized that...
3.
Varelas P, Rehman M, Mehta C, Louchart L, Schultz L, Brady P, et al.
Neurology
. 2021 Jan;
96(10):e1453-e1461.
PMID: 33514644
Objective: To fill the evidence gap on the value of a single brain death (SBD) or dual brain death (DBD) examination by providing data on irreversibility of brain function, organ...
4.
Lioutas V, Goyal N, Katsanos A, Krogias C, Zand R, Sharma V, et al.
J Neurol
. 2019 Dec;
267(4):1053-1062.
PMID: 31848737
Background: Every anticoagulation decision has in inherent risk of hemorrhage; intracerebral hemorrhage (ICH) is the most devastating hemorrhagic complication. We examined whether combining ischemic and hemorrhagic stroke risk in individual...
5.
Lioutas V, Goyal N, Katsanos A, Krogias C, Zand R, Sharma V, et al.
Ann Clin Transl Neurol
. 2019 Aug;
6(8):1546-1551.
PMID: 31402613
Prior studies suggest an association between Vitamin K antagonists (VKA) and cerebral microbleeds (CMBs); less is known about nonvitamin K oral anticoagulants (NOACs). In this observational study we describe CMB...
6.
Lioutas V, Goyal N, Katsanos A, Krogias C, Zand R, Sharma V, et al.
Stroke
. 2018 Oct;
49(10):2309-2316.
PMID: 30355114
Background and Purpose- The aim of this study was to prospectively validate our prior findings of smaller hematoma volume and lesser neurological deficit in nonvitamin K oral anticoagulant (NOAC) compared...
7.
Varelas P, Brady P, Rehman M, Afshinnik A, Mehta C, Abdelhak T, et al.
Neurocrit Care
. 2017 Aug;
27(3):407-414.
PMID: 28828556
Background: Patients with primary posterior fossa catastrophic lesions may clinically meet brain death criteria, but may retain supratentorial brain function or blood flow. These patients could be declared brain-dead in...
8.
Tsivgoulis G, Lioutas V, Varelas P, Katsanos A, Goyal N, Mikulik R, et al.
Neurology
. 2017 Aug;
89(11):1142-1151.
PMID: 28814457
Objective: To compare the neuroimaging profile and clinical outcomes among patients with intracerebral hemorrhage (ICH) related to use of vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) for nonvalvular...
9.
Agarwal R, Mehta C, Kumar A, Maqbool M
Pediatr Neurol
. 2014 Aug;
51(2):282-3.
PMID: 25079579
No abstract available.